Intratio
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-04

CGEM vs IMTX: stock comparison and AI forecast

Cullinan Therapeutics, Inc. (CGEM) and Immatics N.V. (IMTX) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
Nasdaq · Biological Products, (No Diagnostic Substances)

CGEM Cullinan Therapeutics, Inc.

Market Cap
$1.01B
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Nasdaq · Biological Products, (No Diagnostic Substances)

IMTX Immatics N.V.

Price
$7.20 -34.5% · 6M
Market Cap
$965M
P/E Ratio
–
Size
small-cap
AI Forecast
NO CURRENT FORECAST
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

CGEM · IMTX

Key facts

  • CGEM and IMTX have similar market capitalizations ($1.01B and $965M).
  • Both companies share the SEC industry classification Biological Products, (No Diagnostic Substances).
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricCGEMIMTX
Market Cap$1.01B$965M
P/B Ratio3.15x–
EPS–$-2.52
Book Value/Share$5.00–
FCF/Share–$-4.34

Profitability & Margins

MetricCGEMIMTX
ROE-63.6%–
ROA-56.3%–
ROIC-68.6%-57.8%
Tax Rate0.0%-1.2%

Financial Health

MetricCGEMIMTX
Current Ratio8.42x11.72x
D/E Ratio0.13x–
Financial Leverage1.13x–
Interest Coverage-1019.0x–
Working Capital$301M$542M

Cash Flow

MetricCGEMIMTX
Operating Cash Flow-$159M-$537M
Free Cash Flow–-$581M
Capital Spending–-$44M
OCF Growth YoY–-288.2%

Income Statement

MetricCGEMIMTX
Operating Income-$222M-$340M
Net Income-$205M–
R&D Expense$171M$467M

Dividend & Shareholder Information

MetricCGEMIMTX
Shares Outstanding64M134M
FAQ

CGEM vs IMTX: stock comparison and AI forecast

Which is bigger, CGEM or IMTX?

CGEM and IMTX have similar market capitalizations ($1.01B and $965M).

Which one does Intratio's AI model rank higher, CGEM or IMTX?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

Compare

More comparisons

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.